Loading institutional data...
Loading institutional data...
Held by 169 of 5,944 reporting institutions (90th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $427.5M 100.0% | $379.8M 100.0% | $306.6M 100.0% | $204.5M 100.0% | $152.0M 100.0% | $107.5M 100.0% | $76.4M 100.0% |
| Cost of Revenue | — | $260.2M 68.5% | $249.4M 81.3% | $195.4M 95.6% | $194.7M 128.1% | $90.4M 84.1% | $76.7M 100.3% |
| Gross Profit | $122.1M 28.6% | $119.6M 31.5% | $57.2M 18.7% | $9.1M 4.4% | -$42.7M -28.1% | $17.1M 15.9% | -$231K -0.3% |
| Research & Development | $34.1M 8.0% | $41.1M 10.8% | $45.0M 14.7% | $43.5M 21.3% | $34.4M 22.6% | $16.6M 15.5% | $26.0M 34.0% |
| Selling, General & Admin | $57.8M 13.5% | $81.5M 21.5% | $96.8M 31.6% | $102.8M 50.3% | $101.6M 66.9% | $18.8M 17.5% | $15.2M 19.8% |
| Total Operating Expenses | $118.3M 27.7% | $238.3M 62.7% | $165.9M 54.1% | $170.7M 83.5% | $157.4M 103.6% | $49.2M 45.8% | $56.9M 74.4% |
| Operating Income | $7.0M 1.6% | -$116.1M -30.6% | -$106.7M -34.8% | -$159.9M -78.2% | -$194.1M -127.7% | -$29.1M -27.1% | -$53.9M -70.5% |
| Interest Expense | $4.9M 1.1% | $9.7M 2.6% | $2.6M 0.9% | $3.3M 1.6% | $5.4M 3.6% | $5.7M 5.3% | $6.4M 8.3% |
| Interest & Investment Income | — | $3K 0.0% | $438K 0.1% | $70K 0.0% | $0 0.0% | $37K 0.0% | $1.3M 1.6% |
| Other Income (Expense), net | $244K 0.1% | $156K 0.0% | -$713K -0.2% | $944K 0.5% | -$62K -0.0% | $650K 0.6% | -$145K -0.2% |
| Pretax Income | -$34.5M -8.1% | -$195.5M -51.5% | -$106.4M -34.7% | -$158.2M -77.3% | -$206.5M -135.9% | -$33.6M -31.3% | -$59.5M -77.8% |
| Income Tax Expense | -$5.3M -1.2% | $0 0.0% | $10K 0.0% | $33K 0.0% | $0 0.0% | $1K 0.0% | $189K 0.2% |
| Net Income | -$29.2M -6.8% | -$195.5M -51.5% | -$106.3M -34.7% | -$158.2M -77.4% | -$206.5M -135.9% | -$2.4M -2.3% | $3.4M 4.4% |
| Per Share | |||||||
| EPS (Basic) | $-0.09 | $-0.61 | $-0.34 | $-0.52 | $-1.26 | $-0.82 | $-0.06 |
| EPS (Diluted) | $-0.09 | $-0.61 | $-0.34 | $-0.52 | $-1.26 | $-0.82 | $-0.07 |
| Weighted Avg Shares (Basic) | 324.7M | 318.5M | 310.9M | 303.3M | 185.9M | 99.0M | — |
| Weighted Avg Shares (Diluted) | 324.7M | 318.5M | 310.9M | 303.3M | 185.9M | 99.0M | 8.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $56M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 7 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: -6%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 7 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
No current price collected.
Where each multiple sits in its own 7-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 7-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cost of Revenue | 100.3 | 84.1 | 128.1 | 95.6 | 81.3 | 68.5 | — |
| Gross Profit | -0.3 | 15.9 | -28.1 | 4.4 | 18.7 | 31.5 | 28.6 |
| R&D | 34.0 | 15.5 | 22.6 | 21.3 | 14.7 | 10.8 | 8.0 |
| SG&A | 19.8 | 17.5 | 66.9 | 50.3 | 31.6 | 21.5 | 13.5 |
| Operating Income | -70.5 | -27.1 | -127.7 | -78.2 | -34.8 | -30.6 | 1.6 |
| Income Tax | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.2 |
| Net Income | 4.4 | -2.3 | -135.9 | -77.4 | -34.7 | -51.5 | -6.8 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MVST: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~4.6% on $106M of debt.
Cash of $105M fully covers short-term debt of $93M.
Mostly short-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position